PTPN11 and neoplasm: In this study, by utilizing both in vitro co-cultures of tumor spheroids and human immune cells and in vivo syngeneic mouse models, we discovered that inhibiting SHP2 activity alters the cellular composition of the tumor microenvironment through its effect on both tumor and immune cell populations to promote anti-tumor immunity.